AbbVie Inc. Stock Underperforms Wednesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.AbbVie Inc. (ABBV) shares fell 1.09% to $253.30 on Wednesday, underperforming competitors like Johnson & Johnson and Pfizer during a broadly weak market session. The S&P 500 and Dow Jones also declined slightly. AbbVie closed 3.19% below its 52-week high of $261.64 set in July. Trading volume was notably lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) shed 1.09% to $253.30 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.14% to 7,498.96 and Dow Jones Industrial Average falling 0.01% to 52,218.58.
AbbVie Inc. closed 3.19% below its 52-week high of $261.64, which the company achieved on July 2nd.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 2.00% to $255.63, Pfizer Inc. (PFE) fell 0.48% to $24.82, and Amgen Inc. (AMGN) fell 0.05% to $366.05.
Trading volume (4.8 M) remained 2.3 million below its 50-day average volume of 7.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 22, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-22-26 1631ET